ClinicalTrials.govpublic full text
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
chronic heart failure with preserved systolic function, heart failure, dapagliflozin, sglt-2 inhibitors, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 824778
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.